Kamada says it did not capitalize pre-approval commercial inventory costs in 2025, 2024 after SEC query

• Kamada responded to an SEC comment letter on its 2025 Form 20-F, addressing inventory accounting for pre-approval commercial manufacturing.
• It clarified that it did not capitalize costs for inventory produced for commercial sale before regulatory approval in 2025 or 2024.
• Future filings will expand disclosure on assessing “probable future economic benefit” for any pre-approval inventory cost capitalization.
• Planned updates also cover when regulatory or technical feasibility is established, plus the types of pre-approval costs capitalized if material.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kamada Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-106813), on October 05, 2026, and is solely responsible for the information contained therein.